Europass curriculum vitae

Europass
Curriculum Vitae
Personal information
Surname(s) / First name(s) Ferrucci Andrea
Address(es) via Apollo Pizio, num. 3 – 00135 Rome Occupational field Cardiologist
Work experience
Occupation or position held MD, specialist in cardiology Main activities and responsibilities Clinical Management of High-Risk patients, Hypertension Unit, Division of Cardiology, Name and address of employer Division of Cardiology, Faculty of Medicine, University of Rome Sapienza, Sant’Andrea Hospital, Type of business or sector Cardiovascular Medicine Occupation or position held MD, specialist in cardiology Main activities and responsibilities Clinical Management of High-Risk patients, Hypertension Unit, Intensive Coronary Care Unit, Name and address of employer Cardiology Unit, Division of Internal Medicine, Institute of “Malattie Tropicali”, Policlinico Umberto I of Type of business or sector Cardiovascular Medicine Education and training
Title of qualification awarded Specialist in Cardiologist
Occupational skills covered Training Cardiologist providing education and training School of Cardiology, Division of Cardiology, Faculty of Medicine, University of Catania, Catania, Italy. Occupational skills covered Resident Physician For more information on Europass go to ht p:/ europass.cedefop.europa.eu Name and type of organisation Cardiology Unit, Division of Internal Medicine, Institute of “Malattie Tropicali”, Policlinico Umberto I of providing education and training Rome, Rome, Italy. Title of qualification awarded Medical Doctor
Occupational skills covered School of Medicine providing education and training Faculty of Medicine, University of Rome Sapienza, Policlinico Umberto I, Rome, Italy. Personal skills and
competences
Mother tongue(s) Italian
Other language(s) English
Understanding
Speaking
English C1
Society Memberships, Awards
and Honors
Name of the Society Italian Society of Hypertension (SIIA) membership Name of the Society Italian Society of Cardiovascular Prevention (SIPREC) membership Experience as Clinical Trial
Investigator
Title of the Trial Prevalence of Abdominal Obesity and Metabolic Syndrome and Their Association with Organ Damage in Hypertension and Lipid Clinics (PROMISE) Occupational skills covered Sub-Investigator Title of the Trial International Survey Evaluating Microalbuminuria Routinely by Cardiologists in Patients with Occupational skills covered Sub-Investigator Dates 2008 (ongoing)
Genetics and Genomics of Hypertension Associated with microinflammation, oxidative stress, Chronic Title of the Trial Renal Disease and heart failure (InGenious HyperCare): genetics, genomics and proteomics of transition from hypertension to heart failure” Occupational skills covered Sub-Investigator Dates 2008 (ongoing)
For more information on Europass go to ht p:/ europass.cedefop.europa.eu A randomized, double-blind, placebo-controlled, parallel-group study to determine wheter, in patients with type 2 diabetes at high risk for cardiovascular and renal events, aliskiren, on top of conventional Title of the Trial treatment, reduces cardiovascular and renal morbidity and mortality. ALiskiren Trial In Type 2 diabetes Using cardiorenal Disease Endpoints (ALTITUDE) (CSPP100E2337)” (code EUDRACT 2007-000860- Type of the Trial Phase III Interventional Clinical Trial Occupational skills covered Sub-Investigator An eight-week, randomized, double-blind, parallel-group, multicenter study to evaluate the efficacy and safety of the combination of aliskiren / HCTZ (300/12.5 mg and 300/25 mg) in comparison with Title of the Trial aliskiren 300 mg in patients with essential hypertension not adequately responsive to aliskiren 300 mg monotherapy (CSPP100A2332)” (code EUDRACT 2005-004579-39) Type of the Trial Phase III Interventional Clinical Trial Occupational skills covered Sub-Investigator European Trial About Effect of RimoNabant on Abdominal Obese Patients With dysLipidemia Title of the Trial (ETERNAL) (code EUDRACT 2006-001715-30) Type of the Trial Phase III Interventional Clinical Trial Occupational skills covered Sub-Investigator An 8-week double-blind, randomized, active-control, parallel-grupp study to evaluate the efficacy and Title of the Trial safety of the combination of aliskiren / amlodipine / HCTZ to patients with moderate to severe hypertension (CSPA100E2302)” (code EUDRACT 2008-003199-23) Type of the Trial Phase III Interventional Clinical Trial Occupational skills covered Sub-Investigator An 8-week double-blind, multicenter, randomized, multifactorial, placebo-controlled, parallel-group study to evaluate the efficacy and safety of aliskiren administered alone and in combination with Title of the Trial amoldipine in patients with essential hypertension (CSPA100A2305)” (code EUDRACT 2008-001609- Type of the Trial Phase III Interventional Clinical Trial Occupational skills covered Sub-Investigator An 8-week double-blind, multicenter, randomized, multifactorial, placebo-controlled, parallel-group Title of the Trial study to evaluate the efficacy and safety of aliskiren administered alone and in combination with amoldipine in patients with essential hypertension (CSPA100A2305)” (code EUDRACT 2008-001609- Type of the Trial Phase III Interventional Clinical Trial Occupational skills covered Sub-Investigator Efficacy and safety of zofenopril plus hydrochlorothiazide combination versus irbesartan plus Title of the Trial hydrochlorothiazide combination in metabolic syndrome patients with essential hypertension not controlled by previously monotheraphy (MEN/09/ZOF-IPE/001)” (code EUDRACT 2009-012993-10) Occupational skills covered Sub-Investigator For more information on Europass go to ht p:/ europass.cedefop.europa.eu Dates 2010 (ongoing)
A multicentre, multinational, randomised, double-blind, pilot, ascending dose for non responder, parallel group study on the therapeutic efficacy and safety of o.d. Zofenopril 30 mg plus HCTZ 12.5 Title of the Trial mg vs. Irbersartan 150 mg plus HCTZ 12.5 mg in elderly subjects (age > 65 years) affected by Isolated Systolic Hypertension never treated or non responder to previous antihypertensive therapy (monotherapy or association of maximum two treatments) (LUMI/10/ZOF-HYP/001)” (code EUDRACT Type of the Trial Phase III Interventional Clinical Trial Occupational skills covered Sub-Investigator Dates 2011 (ongoing)
A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly Title of the Trial People. Aliskiren Prevention Of Later Life Outcomes (APOLLO) (CSPP100G2301) (code EUDRACT Type of the Trial Phase III Interventional Clinical Trial Occupational skills covered Sub-Investigator For more information on Europass go to ht p:/ europass.cedefop.europa.eu

Source: http://www.dmcm.uniroma1.it/sites/dip-dmcm/files/Ferrucci.pdf